actu.epfl.ch/news/cracking-the-code-of-amorphous-drugs-for-diabete-4

Preview meta tags from the actu.epfl.ch website.

Linked Hostnames

10

Thumbnail

Search Engine Appearance

Google

https://actu.epfl.ch/news/cracking-the-code-of-amorphous-drugs-for-diabete-4

Cracking the code of amorphous drugs for diabetes treatment

Scientists at EPFL and AstraZeneca have developed a method to map the atomic-level structure of amorphous drugs, demonstrated on a GLP-1 receptor agonist candidate for diabetes and obesity treatment.



Bing

Cracking the code of amorphous drugs for diabetes treatment

https://actu.epfl.ch/news/cracking-the-code-of-amorphous-drugs-for-diabete-4

Scientists at EPFL and AstraZeneca have developed a method to map the atomic-level structure of amorphous drugs, demonstrated on a GLP-1 receptor agonist candidate for diabetes and obesity treatment.



DuckDuckGo

https://actu.epfl.ch/news/cracking-the-code-of-amorphous-drugs-for-diabete-4

Cracking the code of amorphous drugs for diabetes treatment

Scientists at EPFL and AstraZeneca have developed a method to map the atomic-level structure of amorphous drugs, demonstrated on a GLP-1 receptor agonist candidate for diabetes and obesity treatment.

  • General Meta Tags

    12
    • title
      Cracking the code of amorphous drugs for diabetes treatment - EPFL
    • charset
      utf-8
    • description
    • DC.language
      en
    • prism.copyright
      @2025 EPFL

  • Open Graph Meta Tags

    7
    • og:title
      Cracking the code of amorphous drugs for diabetes treatment
    • og:description
      Scientists at EPFL and AstraZeneca have developed a method to map the atomic-level structure of amorphous drugs, demonstrated on a GLP-1 receptor agonist candidate for diabetes and obesity treatment.
    • og:type
      article
    • og:url
      https://actu.epfl.ch/news/cracking-the-code-of-amorphous-drugs-for-diabete-4/
    • og:image
      https://actu.epfl.ch/image/154410/1440x810.jpg

  • Twitter Meta Tags

    4
    • twitter:card
      summary_large_image
    • twitter:title
      Cracking the code of amorphous drugs for diabetes treatment
    • twitter:description
      Scientists at EPFL and AstraZeneca have developed a method to map the atomic-level structure of amorphous drugs, demonstrated on a GLP-1 receptor agonist candidate for diabetes and obesity treatment.
    • twitter:image
      https://actu.epfl.ch/image/154410/640x360.jpg

  • Link Tags

    7
    • apple-touch-icon
      //web2018.epfl.ch/8.0.0/icons/apple-touch-icon.png
    • canonical
      https://actu.epfl.ch/news/cracking-the-code-of-amorphous-drugs-for-diabete-4/
    • icon
      //web2018.epfl.ch/8.0.0/icons/favicon-16.png
    • icon
      //web2018.epfl.ch/8.0.0/icons/favicon-32.png
    • shortcut icon
      //web2018.epfl.ch/8.0.0/icons/favicon.ico

Links

33